These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7389992)

  • 1. Blood fluidity and coagulation phenomena in chronic arterial occlusive disease.
    Angelkort B; Boateng K; Maurin N
    J Int Med Res; 1980; 8(3):242-6. PubMed ID: 7389992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of risk factors and coagulation phenomena on the fluidity of blood in chronic arterial occlusive disease.
    Angelkort B; Kiesewetter H
    Scand J Clin Lab Invest Suppl; 1981; 156():185-8. PubMed ID: 6948383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of antithrombotic effect in drug therapy of the chronic arterial occlusive disease.
    Angelkort B
    Ric Clin Lab; 1981; 11 Suppl 1():215-21. PubMed ID: 7188109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Thrombocytic function, plasmatic blood coagulation and fibrinolysis in chronic arterial occlusive disease. Study with pentoxifilline].
    Angelkort B
    Med Welt; 1979 Aug; 30(34):1239-43. PubMed ID: 491921
    [No Abstract]   [Full Text] [Related]  

  • 5. Influence of pentoxifylline on erythrocyte deformability in peripheral occlusive arterial disease.
    Angelkort B; Maurin N; Boateng K
    Curr Med Res Opin; 1979; 6(4):255-8. PubMed ID: 527350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of pentoxifylline on the flow properties of human blood.
    Ehrly AM
    Curr Med Res Opin; 1978; 5(8):608-13. PubMed ID: 710175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement of the flow properties of blood: a new therapeutical approach in occlusive arterial disease.
    Ehrly AM
    Angiology; 1976 Mar; 27(3):188-96. PubMed ID: 1078314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of pentoxifylline on the deformability of erythrocytes and on the muscular oxygen pressure in patients with chronic arterial disease.
    Ehrly AM
    J Med; 1979; 10(5):331-8. PubMed ID: 294470
    [No Abstract]   [Full Text] [Related]  

  • 9. Pentoxifylline treatment in patients with occlusive peripheral arterial disease. Circulatory changes and effects on prostaglandin synthesis.
    Poggesi L; Scarti L; Boddi M; Masotti G; Serneri GG
    Angiology; 1985 Sep; 36(9):628-37. PubMed ID: 3901827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies of the clinical pharmacology and therapeutic efficacy of pentoxifylline in peripheral obstructive arterial disease.
    Di Perri T; Carandente O; Vittoria A; Guerrini M; Messa GL
    Angiology; 1984 Jul; 35(7):427-35. PubMed ID: 6540539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pentoxifylline -- a biomedical profile.
    Müller R
    J Med; 1979; 10(5):307-29. PubMed ID: 393789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Arterial occlusive disease: reducing blood viscosity through drugs].
    Gnauen H
    Med Klin; 1981 Feb; 76(5):144-6. PubMed ID: 7219342
    [No Abstract]   [Full Text] [Related]  

  • 13. [Blood fluidity in essential hypertension, arterial occlusive disease and diabetic angiopathies].
    Sternitzky R; Hänsgen K; Podhaisky H
    Z Gesamte Inn Med; 1991 Nov; 46(16):610-4. PubMed ID: 1792802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Blood rheological changes and their clinical significance in chronic arterial obstructive disease].
    Sternitzky R; Seige K
    Z Gesamte Inn Med; 1983 Jan; 38(1):1-7. PubMed ID: 6342278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On the therapy of disturbances of blood fluidity.
    Mueller R
    Angiology; 1985 Apr; 36(4):226-34. PubMed ID: 3896041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Changes of blood-flow and erythrocyte properties in arterial occlusive diseases].
    Ehrly AM
    Med Welt; 1975 Oct; 26(43):1971-2. PubMed ID: 1196088
    [No Abstract]   [Full Text] [Related]  

  • 17. Blood flow properties and walking performance in chronic arterial occlusive disease.
    Angelkort B; Spürk P; Habbaba A; Mähder M
    Angiology; 1985 May; 36(5):285-92. PubMed ID: 3896044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double-blind, crossover study of the clinical efficacy and the hemorheological effects of pentoxifylline in patients with occlusive arterial disease of the lower limbs.
    Strano A; Davi G; Avellone G; Novo S; Pinto A
    Angiology; 1984 Jul; 35(7):459-66. PubMed ID: 6380350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Failure of pentoxifylline or cilostazol to improve blood and plasma viscosity, fibrinogen, and erythrocyte deformability in claudication.
    Dawson DL; Zheng Q; Worthy SA; Charles B; Bradley DV
    Angiology; 2002; 53(5):509-20. PubMed ID: 12365857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of pentoxifylline on blood viscosity and peripheral hemodynamics in patients with peripheral occlusive arteriopathies].
    Guerrini M; Pecchi S; Rossi C; Cappelli R; Pieragalli D; Acciavatti A
    Ric Clin Lab; 1981; 11 Suppl 1():265-79. PubMed ID: 7188114
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.